The method of how new medication is determined to be cost-effective serves a crucial role in drug access. Here, Ms Man-Chie Chow from the Royal Surrey County Hospital, Guildford, UK discusses the Mind the gap! From the latest scientific advances in multiple myeloma to the reality of patient access in the UK talk at the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK. Ms Chow focuses on the issue of drug funding, particularly for multiple myeloma, and the problems with the methods of analysis NICE employs to evaluate new additions to current treatments.
Mind the gap! Drug funding and access
